Corrigendum to “A single application of the epithelial sodium channel inhibitor BI 1265162 significantly improves water transport and mucociliary clearance of cystic fibrosis epithelial tissue, alone or combined with lumacaftor/ivacaftor or isoproterenol” Journal of Cystic Fibrosis 18 S1 (2019) S41/ePS1.07